Physiological behavior of quantum dots

Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology

Volumn 4, Issue 6, 2012, Pages 620-637

  Xu, Ligeng ^a   Chen, Chunying ^a  

^a NATIONAL CENTER FOR NANOSCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ABSORPTION CROSS SECTIONS; BIO-IMAGING; BIOLOGICAL IMPACTS; BIOMEDICAL APPLICATIONS; CRUCIAL PARAMETERS; FLUORESCENCE EMISSION; IN-VIVO; PHOTO-STABILITY;

FLUORESCENCE; MEDICAL APPLICATIONS; METABOLISM; PHYSIOLOGY; TOXICITY; WIRE;

SEMICONDUCTOR QUANTUM DOTS;

NANOMATERIAL; QUANTUM DOT;

ABSORPTION; BIOMEDICINE; CELL FATE; CELL METABOLISM; CHEMICAL MODIFICATION; DIAGNOSTIC IMAGING; FLUORESCENCE; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR IMAGING; NANOMEDICINE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; REVIEW; SURFACE PROPERTY;

ANIMALS; BIOSENSING TECHNIQUES; HUMANS; MOLECULAR IMAGING; QUANTUM DOTS;

EID: 84867696543     PISSN: 19395116     EISSN: 19390041     Source Type: Journal    
DOI: 10.1002/wnan.1187     Document Type: Review

References (90)

1. Chan WCW, Maxwell DJ, Gao XH, Bailey RE, Han MY, Nie SM. Luminescent quantum dots for multiplexed biological detection and imaging. Curr Opin Biotechnol 2002, 13:40-46.
2. Klostranec JM, Chan WCW. Quantum dots in biological and biomedical research: recent progress and present challenges. Adv Mater 2006, 18:1953-1964.
3. Murray CB, Norris DJ, Bawendi MG. Synthesis and characterization of nearly monodisperse CdE (E = sulfur, selenium, tellurium) semiconductor nanocrystallites. J Am Chem Soc 1993, 115:8706-8715.
4. Wu X, Liu H, Liu J, Haley KN, Treadway JA, Larson JP, Ge N, Peale F, Bruchez MP. Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots. Nat Biotechnol 2003, 21:41-46.
5. Derfus AM, Chan WCW, Bhatia SN. Probing the cytotoxicity of semiconductor quantum dots. Nano Lett 2004, 4:11-18.
6. Kirchner C, Liedl T, Kudera S, Pellegrino T, Munoz Javier A, Gaub HE, Stolzle S, Fertig N, Parak WJ. Cytotoxicity of colloidal CdSe and CdSe/ZnS nanoparticles. Nano Lett 2005, 5:331-338.
7. Dubertret B, Skourides P, Norris DJ, Noireaux V, Brivanlou AH, Libchaber A. In vivo imaging of quantum dots encapsulated in phospholipid micelles. Science 2002, 298:1759-1762.
8. Akerman ME, Chan WCW, Laakkonen P, Bhatia SN, Ruoslahti E. Nanocrystal targeting in vivo. Proc Natl Acad Sci USA 2002, 99:12617-12621.
9. Kim S, Lim YT, Soltesz EG, De Grand AM, Lee J, Nakayama A, Parker JA, Mihalijevic T, Laurence RG, Dor DM, et al. Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping. Nat Biotechnol 2004, 22:93-97.
10. Gao XH, Cui YY, Levenson RM, Chung LWK, Nie SM. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol 2004, 22:969-976.
11. Voura EB, Jaiswal JK, Mattoussi H, Simon SM. Tracking metastatic tumor cell extravasation with quantum dot nanocrystals and fluorescence emission-scanning. Nat Med 2004, 10:993-998.
12. Lao F, Chen L, Li W, Ge CC, Qu Y, Sun QM, Zhao YL, Han D, Chen CY. Fullerene nanoparticles selectively enter oxidation-damaged cerebral microvessel endothelial cells and inhibit JNK-related apoptosis. ACS Nano 2009, 3:3358-3368.
13. Qiu Y, Liu Y, Wang LM, Xu LG, Bai R, Ji YL, Wu XC, Zhao YL, Li YF, Chen CY. Surface chemistry and aspect ratio mediated cellular uptake of Au nanorods. Biomaterials 2010, 31:7606-7619.
14. Wang LM, Li YF, Zhou LJ, Liu Y, Meng L, Zhang K, Wu XC, Zhang LL, Li B, Chen CY. Characterization of gold nanorods in vivo by integrated analytical techniques: their uptake, retention, and chemical forms. Anal Bioanal Chem 2010, 396:1105-1114.
15. Ge CC, Du JF, Zhao LN, Wang LM, Liu Y, Li DH, Yang YL, Zhou RH, Zhao YL, Chai ZF, et al. Binding of blood proteins to carbon nanotubes reduces cytotoxicity. Proc Natl Acad Sci USA 2011, 108:16968-16973.
16. Zhao YL, Xing G, Chai ZF. Nanotoxicology: are carbon nanotubes safe? Nat Nanotechnol 2008, 3:191-192.
17. Li Y, Liu Y, Fu YJ, Wei TT, Le Guyader L, Gao G, Liu RS, Chang YZ, Chen CY. The triggering of apoptosis in macrophages by pristine graphene through the MAPK and TGF-β signaling pathways. Biomaterials 2012, 33:402-411.
18. Zhao F, Zhao Y, Liu Y, Chang XL, Chen CY, Zhao YL. Cellular uptake, intracellular trafficking, and cytotoxicity of nanomaterials. Small 2011, 7:1322-1337.
19. Li YF, Chen CY. Fate and toxicity of metallic and metal-containing nanoparticles for biomedical applications. Small 2011, 7:2965-2980.
20. Hanaki K, Momo A, Oku T, Komoto A, Maenosono S, Yamaguchi Y, Yamamoto K. Semiconductor quantum dot/albumin complex is a long life and highly photostable endosome marker. Biochem Biophys Res Commun 2003, 302:496-501.
21. Medintz IL, Uyeda HT, Goldman ER, Mattoussi H. Quantum dot bioconjugates for imaging, labelling and sensing. Nat Mater 2005, 4:435-446.
22. Chang E, Thekkek N, Yu WW, Colvin VL, Drezek R. Evaluation of quantum dot cytotoxicity based on intracellular uptake. Small 2006, 2:1412-1417.
23. Medintz IL, Uyeda HT, Goldman ER, Mattoussi H. Quantum dot bioconjugates for imaging, labelling and sensing. Nat Mater 2005, 4:435-446.
24. Hild WA, Breunig M, Goepferich A. Quantum dots-nanosized probes for the exploration of cellular and intercellular targeting. Eur J Pharm Biopharm 2008, 68:153-168.
25. Zhou M, Ghosh I. Current trends in peptide science quantum dots and peptides: a bright future together. Biopolymers 2006, 88:325-339.
26. Hoshino A, Fujioka K, Oku T, Nakamura S, Suga M, Yamaguchi Y, Suzuki K, Yasuhara M, Yamamoto K. Quantum dots targeted to the assigned organelle in living cells. Microbiol Immunol 2004, 48:985-994.
27. Medintz IL, Pons T, Trammell SA, Grimes AF, English DS, Blanco-Canosa JB, Dawson PE, Mattoussi H. Interactions between redox complexes and semiconductor quantum dots coupled via a peptide bridge. J Am Chem Soc 2008, 130:16745-16756.
28. Walther C, Meyer K, Rennert R, Neundorf I. Quantum dot carrier peptide conjugates suitable for imaging and delivery applications. Bioconjug Chem 2008, 19:2346-2356.
29. Xiong RL, Li Z, Mi L, Wang PN, Chen JY, Wang LX, Yang WL. Study on the intracellular fate of Tat peptide-conjugated quantum dots by spectroscopic investigation. J Fluoresc 2010, 20:551-556.
30. Pi MQ, Zhang WJ, Zhou GD, Liu W, Cao YL. Degradation or excretion of quantum dots in mouse embryonic stem cells. BMC Biotechnol 2010, 10:36-44.
31. Lovric J, Bazzi HS, Cuie Y, Fortin GRA, Winnik FM, Maysinger D. Differences in subcellular distribution and toxicity of green and red emitting CdTe quantum dots. J Mol Med 2008, 83:377-385.
32. Li YY, Zhou YL, Wang HY, Perrett S, Zhao YL, Tang ZY, Nie GJ. Chirality of glutathione surface coating affects the cytotoxicity of quantum dots. Angew Chem Int Ed Engl 2011, 50:5860-5864.
33. Ma N, Marshall AF, Gambhir SS, Rao JH. Facile synthesis, silanization, and biodistribution of biocompatible quantum dots. Small 2010, 6:1520-1528.
34. Choi HS, Liu W, Misra P, Tanaka E, Zimmer JP, Ipe BI, Bawendi MG, Frangioni JV. Renal clearance of quantum dots. Nat Biotechnol 2007, 25:1165-1170.
35. Su YY, Peng F, Jiang ZY, Zhong YL, Lu YM, Jiang XX, Huang Q, Fan CH, Lee ST, He Y. In vivo distribution, pharmacokinetics, and toxicity of aqueous synthesized cadmium-containing quantum dots. Biomaterials 2011, 32:5855-5862.
36. Chen Z, Chen H, Meng H, Xing GM, Gao XY, Sun BY, Shi XL, Yuan H, Zhang CC, Liu R, et al. Bio-distribution and metabolic paths of silica coated CdSeS quantum dots. Toxicol Appl Pharm 2008, 230:364-371.
37. Lin CH, Chang LW, Chang H, Yang MS, Yang CS, Lai WH, Chang WH, Lin PP. The chemical fate of the Cd/Se/Te-based quantum dot 705 in the biological system: toxicity implications. Nanotechnology 2009, 20:215101.
38. Pelley JL, Daar AS, Saner MA. State of academic knowledge on toxicity and biological fate of quantum dots. Toxicol Sci 2009, 112:276-296.
39. Praetner M, Rehberg M, Bihari P, Lerchenberger M, Uhl B, Holzer M, Eichhorn ME, Furst R, Perisic T, Reichel CA, et al. The contribution of the capillary endothelium to blood clearance and tissue deposition of anionic quantum dots in vivo. Biomaterials 2010, 31:6692-6700.
40. Cedervall T, Lynch I, Lindman S, Berggard T, Thulin E, Nillson H, Dawson KA, Linse S. Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc Natl Acad Sci USA 2007, 104:2050-2055.
41. Lynch I, Dawson KA. Protein-nanoparticle interactions. Nanotoday 2008, 3:40-47.
42. Lundqvist M, Stigler J, Elia G, Lynch I, Cerdervall T, Dawson KA. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci USA 2008, 105:14265-14270.
43. Casals E, Pfaller T, Duschl A, Oostingh GJ, Puntes V. Time evolution of the nanoparticle protein corona. ACS Nano 2010, 4:3623-3632.
44. Dell'Orco D, Lundqvist M, Oslakovic C, Cedervall T, Linse S. Modeling the time evolution of the nanoparticle-protein corona in a body fluid. PLoS One 2010, 5:e10949.
45. Lynch I, Dawson KA, Linse S. Detecting cryptic epitopes created by nanoparticles. Sci STKE 2006, 327:pe14.
46. Lundqvist M, Stigler J, Cerdervall T, Berggard T, Flanagan MB, Lynch I, Elia G, Dawson K. The evolution of the protein corona around nanoparticles: a test study. ACS Nano 2011, 5:7503-7509.
47. Han Y, Xie GY, Sun ZW, Mu Y, Han SH, Xiao Y, Liu N, Wang H, Guo CX, Shi ZX, et al. Plasma kinetics and biodistribution of water-soluble CdTe quantum dots in mice: a comparison between Cd and Te. J Nanopart Res 2011, 13:5373-5380.
48. Kato S, Itoh K, Yaoi T, Tozawa T, Yashikawa Y, Yasui H, Kanamura N, Hoshino A, Manabe N, Yamamoto K, et al. Organ distribution of quantum dots after intraperitoneal administration, with special reference to area-specific distribution in the brain. Nanotechnology 2010, 21:335103.
49. Gopee NV, Roberts DW, Webb P, Cozart CR, Siitonen PH, Warbritton AR, Yu WW, Colvin VL, Walker NJ, Howard PC. Migration of intradermally injected quantum dots to sentinel organs in mice. Toxicol Sci 2007, 98:249-257.
50. Robe A, Pic E, Lassalle HP, Bezdetnaya L, Guillemin F, Marchal F. Quantum dots in axillary lymph node mapping: biodistribution study in healthy mice. BMC Cancer 2008, 8:111.
51. Pic E, Pons T, Bezdetnaya L, Leroux A, Guillemin F, Dubertret B, Marchal F. Fluorescence imaging and whole-body biodistribution of near-infrared-emitting quantum dots after subcutaneous injection for regional lymph node mapping in mice. Mol Imaging Biol 2010, 12:394-405.
52. Choi HS, Liu W, Misra P, Tanaka E, Zimmer JP, Ipe BI, Bawendi MG, Frangioni JV. Renal clearance of quantum dots. Nat Biotechnol 2007, 25:1165-1170.
53. Schipper ML, Lyer G, Koh AL, Cheng Z, Ebenstein Y, Aharoni A, Keren S, Bentolila LA, Li JQ, Rao JH, et al. Particle size, surface coating, and PEGylation influence the biodistribution of quantum dots in living mice. Small 2009, 5:126-134.
54. Fischer HC, Liu LC, Pang KS, Chan WCW. Pharmacokinetics of nanoscale quantum dots: in vivo distribution, sequestration, and clearance in the rat. Adv Funct Mater 2006, 16:1299-1305.
55. Ryman-Rasmussen JP, Riviere JE, Monteiro-Riviere NA. Penetration of intact skin by quantum dots with diverse physicochemical properties. Toxicol Sci 2006, 91:159-165.
56. Yang RSH, Chang LW, Wu JP, Tsai MH, Wang HJ, Kuo YC, Yeh TK, Yang CS, Lin PP. Persistent tissue kinetics and redistribution of nanoparticles, quantum dot 705, in mice: ICP-MS quantitative assessment. Environ Health Perspect 2007, 115:1339-1343.
57. Comsa DC, Farrell TJ, Patterson MS. Quantification of bioluminescence images of point source objects using diffusion theory models. Phys Med Biol 2006, 51:3733-3746.
58. Tseng JR, Dandekar M, Subbarayan M, Cheng Z, Park JM, Louie S, Gambhir SS. Reproducibility of 39-deoxy-39-18F-fluorothymidine microPET studies in tumor xenografts in mice. J Nucl Med 2005, 46:1851-1857.
59. Schipper ML, Cheng Z, Lee SW, Bentolila LA, Lyer G, Rao JH, Chen XY, Wu AM, Weiss S, Gambhir SS. MicroPET-based biodistribution of quantum dots in living mice. J Nucl Med 2007, 48:1511-1518.
60. Park JJ, Lee TS, Kang JH, Song S, Cheon GJ. Radioiodination and biodistribution of quantum dots using Bolton-Hunter reagent. Appl Radiat Isot 2011, 69:56-62.
61. Uzun O, Hu Y, Hu Y, Han HS, Watson N, Chen S, Irvine DJ, Stellacci F. Surface structure-regulated cell membrane penetration by monolayer protected nanoparticles. Nat Mater 2008, 7:588-595.
62. Sanhai WR, Sakamoto JH, Canady R, Ferrari M. Seven challenges for nanomedicine. Nat Nanotechnol 2008, 3:242-244.
63. Liu Z, Tabakman S, Welsher K, Dai HJ. Carbon nanotubes in biology and medicine: in vitro and in vivo detection, imaging and drug delivery. Nano Res 2009, 2:85-120.
64. Qu Y, Li W, Zhou YL, Liu XF, Zhang LL, Wang LM, Li YF, Iida A, Tang ZY, Zhao YL, et al. Full assessment of fate and physiological behavior of quantum dots utilizing caenorhabditis elegans as a model organism. Nano Lett 2011, 11:3174-3183.
65. Al-Salim N, Barraclough E, Burgess E, Clothier B, Deurer M, Green S, Malone L, Weir G. Quantum dot transport in soil, plants, and insects. Sci Total Environ 2011, 409:3237-3248.
66. Altun ZF, Hall DH. Introduction. In: WormAtlas, 2009. doi:10.3908/wormatlas.1.1.
67. Hardman R. A toxicologic review of quantum dots: toxicity depends on physicochemical and environmental factors. Environ Health Perspect 2006, 114:165-172.
68. Rzigalinski BA, Strobl JS. Cadmium-containing nanoparticles: perspectives on pharmacology and toxicology of quantum dots. Toxicol Appl Pharm 2009, 238:280-288.
69. Bottrill M, Green M. Some aspects of quantum dot toxicity. Chem Commun 2011, 47:7039-7050.
70. Hoshino A, Hanada S, Yamamoto K. Toxicity of nanocrystal quantum dots: the relevance of surface modifications. Arch Toxicol 2011, 85:707-720.
71. Chen N, He Y, Su YY, Li XM, Huang Q, Wang HF, Zhang XZ, Tai RZ, Fan CH. The cytotoxicity of cadmium-based quantum dots. Biomaterials 2012, 33:1238-1244.
72. Gosso S, Gavello D, Giachello CNG, Franchino C, Carbone E, Carabelli V. The effect of CdSe-ZnS quantum dots on calcium currents and catecholamine secretion in mouse chromaffin cells. Biomaterials 2011, 32:9040-9050.
73. Li JH, Zhang Y, Xiao Q, Tian FF, Liu XR, Li R, Zhao GY, Jiang FL, Liu Y. Mitochondria as target of quantum dots toxicity. J Hazard Mater 2011, 194:440-444.
74. Yan M, Zhang Y, Xu KD, Fu T, Qin HY, Zheng XX. An in vitro study of vascular endothelial toxicity of CdTe quantum dots. Toxicology 2011, 282:94-103.
75. Zhang LW, Baumer W, Monteiro-Riviere NA. Cellular uptake mechanisms and toxicity of quantum dots in dendritic cells. Nanomedicine 2011, 6:777-791.
76. Liu W, Zhang SP, Wang LX, Qu C, Zhang CW, Hong L, Yuan L, Huang ZH, Wang Z, Liu SJ, et al. CdSe quantum dot (QD)-induced morphological and functional impairments to liver in mice. PLoS One 2011, 6:e24406.
77. Chu MQ, Wu Q, Yang H, Yuan RQ, Hou SK, Yang YF, Zou YJ, Xu S, Xu KY, Ji AL, et al. Transfer of quantum dots from pregnant mice to pups across the placental barrier. Small 2010, 6:670-678.
78. Lei Y, Xiao Q, Huang S, Xu WS, Zhang Z, He ZK, Liu Y, Deng FJ. Impact of CdSe/ZnS quantum dots on the development of zebrafish embryos. J Nanopart Res 2011, 13:6895-6906.
79. Gomes SAO, Vieira CS, Almeida DB, Santos-Mallet JR, Menna-Barreto RFS, Cesar CL, Feder D. CdTe and CdSe quantum dots cytotoxicity: a comparative study on microorganisms. Sensors 2011, 11:11664-11678.
80. Wang LL, Zheng HZ, Long YJ, Gao M, Hao JY, Du J, Mao XJ, Zhou DB. Rapid determination of the toxicity of quantum dots with luminous bacteria. J Hazard Mater 2010, 177:1134-1137.
81. Silver S. Bacterial resistances to toxic metal ions-a review. Gene 1996, 179:9-19.
82. Vieira CS, Almeida DB, de Thomaz AA, Menna-Barreto RFS, Santos-Mallet JR, Cesar CL, Gomes SAO, Feder D. Studying nanotoxic effects of CdTe quantum dots in Trypanosoma cruzi. Mem Inst Oswaldo Cruz 2011, 106:158-165.
83. Lee J, Ji K, Kim J, Park C, Lim KH, Yoon TH, Choi K. Acute toxicity of two CdSe/ZnSe quantum dots with different surface coating in Daphnia magna under various light conditions. Environ Toxicol 2010, 25:593-600.
84. Oesterling E, Chopra N, Gavalas V, Arzuaga X, Lim EJ, Sultana R, Butterfield D A, Bachas L, Hennig B. Alumina nanoparticles induce expression of endothelial cell adhesion molecules. Toxicol Lett 2008, 178:160-166.
85. Lee HM, Shin DM, Song HM, Yuk JM, Lee ZW, Lee SH, Hwang SM, Kim JM, Lee CS, Jo EK. Nanoparticles up-regulate tumor necrosis factor-α and CXCL8 via reactive oxygen species and mitogen-activated protein kinase activation. Toxicol Appl Pharmacol 2009, 238:160-169.
86. Kang CM, Jang AS, Ahn MH, Shin JA, Kim JH, Choi YS, Rhim TY, Park CS. Interleukin-25 and interleukin-13 production by alveolar macrophages in response to particles. Am J Respir Cell Mol Biol 2005, 33:290-296.
87. Rehberg M, Praetner M, Leite CF, Reichel CA, Bihari P, Mildner K, Duhr S, Zeuschner D, Krombach F. Quantum dots modulate leukocyte adhesion and transmigration depending on their surface modification. Nano Lett 2010, 10:3656-3664.
88. Rehberg M, Leite CF, Mildner K, Horstkotte J, Zeuschner D, Krombach F. Surface chemistry of quantum dots determines their behavior in postischemic tissue. ACS Nano 2012, 6:1370-1379.
89. Xu LG, Liu Y, Chen ZY, Li W, Liu Y, Wang LM, Liu Y, Wu XC, Ji YL, Zhao YL, et al. Surface-engineered gold nanorods: promising DNA vaccine adjuvant for HIV-1 treatment. Nano Lett 2012, 12:2003-2012.
90. Xu LG, Liu Y, Bai R, Chen CY. Applications and toxicological issues surrounding nanotechnology in the food industry. Pure Appl Chem 2010, 82:349-372.